Understanding the Safety Profile of NAD+ Therapy

As interest in NAD+ therapy continues to grow, one of the most common questions people ask is whether the treatment is safe.

NAD+ (nicotinamide adenine dinucleotide) is a naturally occurring coenzyme found in every living cell. It plays an essential role in cellular energy production, mitochondrial function and numerous metabolic processes that support normal human physiology.

Because NAD+ is naturally present in the body, many people assume that intravenous NAD+ therapy is completely risk-free. However, like any medical treatment, it should only be considered after an appropriate medical assessment and under the supervision of qualified healthcare professionals.

This article explores what current medical evidence tells us about the safety of NAD+ therapy, the side effects that have been reported and why personalised medical assessment remains essential before treatment.

What Is NAD+ Therapy?

NAD+ therapy involves administering nicotinamide adenine dinucleotide through an intravenous infusion.

Unlike oral supplements, intravenous administration delivers NAD+ directly into the bloodstream under controlled medical supervision.

The infusion is usually administered gradually over several hours, allowing healthcare professionals to monitor the patient's comfort and adjust the infusion rate if necessary.

The objective is not simply to administer NAD+, but to ensure that treatment is appropriate for the individual's medical history, current symptoms and overall health.

Is NAD+ Naturally Found in the Body?

Yes.

NAD+ is an essential molecule present in virtually every cell of the human body.

It is involved in hundreds of biochemical reactions, including:

• Cellular energy production
• Mitochondrial function
• DNA repair
• Cellular signalling
• Metabolic regulation
• Activation of enzymes involved in healthy cellular maintenance

Because NAD+ is naturally produced by the body, researchers have become increasingly interested in understanding how changes in NAD+ metabolism may influence health and ageing.

However, naturally occurring does not automatically mean that intravenous administration is appropriate for everyone.

Is NAD+ Therapy Considered Safe?

Based on the available scientific literature, NAD+ therapy appears to be generally well tolerated when administered under appropriate medical supervision.

Most published studies have reported relatively few serious adverse events.

However, it is important to recognise that research remains limited, particularly regarding long-term safety and the effectiveness of repeated treatments.

Current evidence suggests that NAD+ therapy should be viewed as an emerging area of medicine rather than an established treatment for specific medical conditions.

As with any intravenous therapy, safety depends not only on the substance being administered but also on proper patient selection, medical supervision and appropriate infusion protocols.

Why Medical Assessment Is Essential

Not everyone experiencing fatigue, reduced concentration or low energy is an appropriate candidate for NAD+ therapy.

Many of these symptoms are caused by common and treatable medical conditions, including:

• Iron deficiency
• Vitamin B12 deficiency
• Thyroid disorders
• Anaemia
• Sleep disorders
• Diabetes
• Chronic infections
• Medication side effects

For this reason, physicians generally recommend identifying potential underlying causes before considering supportive therapies such as NAD+.

A comprehensive medical assessment may include:

• Review of symptoms
• Medical history
• Medication review
• Physical examination
• Appropriate laboratory investigations
• Individualised treatment planning

This approach helps ensure that patients receive the most appropriate care rather than simply treating symptoms.

Why Is NAD+ Infused Slowly?

One of the distinctive features of NAD+ therapy is that it is typically administered more slowly than many other intravenous infusions.

This is because some individuals may experience temporary infusion-related symptoms if NAD+ is delivered too rapidly.

Reducing the infusion rate often improves comfort and allows treatment to continue safely.

For this reason, experienced medical teams monitor patients throughout the infusion and adjust the administration rate according to individual tolerance.

Does the Infusion Rate Affect Comfort?

Yes.

Clinical experience suggests that infusion speed can influence how comfortable a patient feels during treatment.

Some people tolerate NAD+ infusions with minimal discomfort, while others may experience temporary symptoms that improve when the infusion is slowed.

This is one reason why NAD+ therapy should always be administered in an appropriate clinical setting where patients can be monitored throughout the treatment.

Does "Natural" Mean Risk-Free?

Not necessarily.

Many substances naturally produced by the human body can still cause unwanted effects when administered therapeutically.

The safety of any treatment depends on factors such as:

• Individual health status
• Medical history
• Existing medical conditions
• Other medications
• Infusion protocol
• Clinical supervision

For this reason, decisions regarding NAD+ therapy should always be made on an individual basis following medical assessment.

Current Medical Perspective
The current scientific consensus can be summarised as follows:

• NAD+ is an essential molecule naturally present in the human body.
• Intravenous NAD+ therapy has generally demonstrated a favourable short-term safety profile in published studies.
• Research remains limited.
• Long-term clinical data are still developing.
• NAD+ therapy should only be considered following appropriate medical evaluation and under qualified medical supervision.

What Side Effects Have Been Reported?

Based on the available medical literature, NAD+ therapy is generally well tolerated when administered under appropriate medical supervision. Most reported side effects are mild, temporary and tend to resolve either during the infusion or shortly afterwards.

It is important to remember that the published evidence remains relatively limited, particularly regarding long-term use. As research continues, our understanding of both the benefits and safety profile of NAD+ therapy is expected to evolve.

Common Side Effects

Some patients may experience temporary infusion-related symptoms, particularly if the infusion is administered too quickly.

Reported side effects include:

• Temporary nausea
• Sensation of warmth or flushing
• Mild chest or abdominal discomfort
• Headache
• Fatigue during the infusion
• Muscle tightness
• Light-headedness
• Local discomfort at the IV site

These symptoms are usually mild and often improve by slowing the infusion rate.

Many patients complete treatment without experiencing significant side effects.

Why Does Infusion Speed Matter?

Unlike many standard intravenous vitamin infusions, NAD+ is commonly administered over a longer period.

Clinical experience suggests that a slower infusion rate improves comfort for many patients.

If temporary symptoms develop, healthcare professionals can usually reduce the infusion speed, allowing symptoms to settle before continuing treatment.

This individualised approach is one reason why NAD+ therapy should be administered under appropriate medical supervision.

Are Serious Side Effects Common?

Based on the available published studies, serious adverse events appear to be uncommon.

However, it is important to recognise that:

• Human clinical studies remain relatively small.
• Long-term safety data are limited.
• More high-quality research is needed.

As with any intravenous therapy, there are general risks associated with IV treatment itself, including bruising, discomfort at the injection site, infection or inflammation of the vein, although these complications are uncommon when appropriate clinical procedures are followed.

Who May Not Be a Suitable Candidate?

NAD+ therapy is not appropriate for everyone.

The decision to proceed with treatment should always be based on an individual medical assessment.

Depending on your medical history, your physician may advise against treatment or recommend further investigation first.

Examples include individuals with:

• Unexplained symptoms requiring diagnosis
• Acute illness or infection
• Certain unstable medical conditions
• Known allergies to treatment components
• Conditions where intravenous therapy may not be appropriate

Because every patient is different, there is no universal list that applies to everyone.

Why a Medical Assessment Comes First

Many symptoms that prompt people to consider NAD+ therapy—including fatigue, reduced concentration and poor recovery—can have numerous underlying causes.

Before recommending treatment, physicians may evaluate for:

• Iron deficiency
• Vitamin B12 deficiency
• Vitamin D deficiency
• Thyroid disorders
• Anaemia
• Diabetes
• Sleep disorders
• Chronic infections
• Hormonal imbalances
• Medication-related side effects

Identifying and treating these conditions often provides the greatest clinical benefit.

What Does Current Research Say About Safety?

Most available human studies have primarily evaluated:

• Safety
• Tolerability
• Changes in NAD+ levels
• Pharmacokinetics
• Metabolic effects

Overall, the published literature suggests that NAD+ therapy has a favourable short-term safety profile when administered appropriately.

However, researchers consistently emphasise that:

• Larger clinical trials are needed.
• Long-term outcomes remain uncertain.
• Evidence for effectiveness varies depending on the condition being studied.

This is why NAD+ therapy should currently be viewed as an emerging therapeutic approach rather than a universally established treatment.

The Importance of Medical Supervision

Medical supervision is essential throughout the treatment process.

Healthcare professionals monitor patients to:

• Confirm suitability before treatment
• Review medical history
• Assess current symptoms
• Monitor comfort during the infusion
• Adjust infusion speed if necessary
• Manage any unexpected reactions
  
  

This careful approach helps maximise patient safety while ensuring treatment is tailored to the individual.

Current Medical Consensus

The available evidence suggests:

• NAD+ therapy is generally well tolerated when administered under medical supervision.
• Most reported side effects are mild and temporary.
• Slower infusion rates may improve patient comfort.
• Serious adverse events appear to be uncommon, although long-term data remain limited.
• Medical assessment is essential to determine whether treatment is appropriate for each individual.

Is NAD+ Therapy Right for Everyone?

NAD+ therapy has attracted growing interest among people seeking to optimise their health, improve recovery or address symptoms such as fatigue and brain fog. However, it is important to understand that no medical treatment is appropriate for everyone.

The decision to proceed with NAD+ therapy should always follow a comprehensive medical assessment that considers your symptoms, medical history, current medications and overall health.

Rather than asking whether NAD+ therapy is "safe" in general, the more appropriate question is whether it is safe and suitable for you as an individual.

The Importance of Personalised Medicine

Modern medicine increasingly recognises that treatments should be tailored to each patient rather than following a one-size-fits-all approach.

Two people with similar symptoms may have completely different underlying causes.

For example, persistent fatigue may be caused by:

• Iron deficiency
• Vitamin B12 deficiency
• Thyroid disease
• Poor sleep
• Chronic stress
• Depression
• Long COVID
• Medication side effects

Treating these underlying conditions is often more beneficial than focusing solely on symptom management.

For this reason, a personalised medical assessment remains the cornerstone of appropriate care.

Frequently Asked Questions

Is NAD+ therapy approved for treating fatigue or brain fog?

At present, NAD+ therapy is not considered a standard treatment for fatigue, brain fog or healthy ageing.

Research is ongoing, and although the biological rationale is promising, more high-quality clinical trials are required before firm treatment recommendations can be made.

Is NAD+ therapy generally well tolerated?

Current published studies suggest that NAD+ therapy is generally well tolerated when administered under appropriate medical supervision.

Most reported side effects are mild, temporary and often related to the rate of infusion rather than the NAD+ molecule itself.

Can NAD+ therapy be combined with other treatments?

This depends on your individual circumstances.

Your physician will consider your medical history, current medications and treatment goals before recommending whether NAD+ therapy should form part of your personalised care plan.

Do I need blood tests before treatment?

In many cases, yes.

Blood tests may help identify common and treatable causes of symptoms such as fatigue or poor concentration.

Depending on your clinical presentation, your physician may recommend investigations including:

• Full blood count
• Ferritin
• Vitamin B12
• Folate
• Vitamin D
• Thyroid function
• Blood glucose
• Kidney and liver function
• Inflammatory markers

These results help guide treatment decisions and ensure that important medical conditions are not overlooked.

How can I reduce the risk of side effects?

The safest approach includes:

• Having a comprehensive medical assessment beforehand
• Receiving treatment in an appropriate clinical setting
• Ensuring the infusion is administered at an appropriate rate
• Remaining under medical supervision throughout the treatment
• Reporting any discomfort promptly during the infusion

These measures help optimise patient comfort and safety.

Key Takeaways

• NAD+ is a naturally occurring coenzyme essential for cellular energy production.
• Current evidence suggests that intravenous NAD+ therapy is generally well tolerated when administered under appropriate medical supervision.
• Most reported side effects are mild, temporary and often improve by adjusting the infusion rate.
• Serious adverse events appear to be uncommon, although long-term clinical data remain limited.
• NAD+ therapy is not currently considered an established treatment for fatigue, brain fog or healthy ageing.
• A comprehensive medical assessment is essential to determine whether NAD+ therapy is appropriate for your individual circumstances.
• More high-quality clinical research is needed to better understand both the long-term safety and effectiveness of NAD+ therapy.

About Dr. Indhira Ghyssaert

Dr. Indhira Ghyssaert is a General Practitioner with a special interest in preventive, integrative and personalised medicine. She provides comprehensive medical assessments designed to identify the underlying causes of symptoms rather than simply treating them in isolation.

At Galatzó Health, Dr. Ghyssaert combines evidence-based medicine with advanced laboratory testing and personalised treatment plans to help patients optimise their health and wellbeing.

Medical Disclaimer

This article is intended for educational purposes only and should not be considered medical advice.

The information provided does not replace an individual medical consultation, diagnosis or treatment. If you are considering NAD+ therapy or are experiencing persistent symptoms such as fatigue, reduced concentration or poor recovery, you should seek assessment from a qualified healthcare professional.

Treatment recommendations should always be based on a comprehensive medical evaluation and your individual clinical circumstances.

Book a Medical Assessment

If you would like to learn whether NAD+ therapy may be appropriate for your individual health needs, a comprehensive medical assessment can help guide evidence-based treatment decisions.

Your consultation may include:

• Comprehensive medical consultation
• Detailed medical history and clinical assessment
• Review of previous laboratory results
• Personalised blood test recommendations
• Individualised treatment recommendations
• Ongoing medical follow-up when appropriate

Galatzó Health
Mallorca

www.galatzohealth.com

+34 655 726 050

Scientific References

1. Conze D, Brenner C, Kruger CL. Safety and Metabolism of Long-Term Administration of Nicotinamide Riboside in Healthy Adults. Scientific Reports.
2. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ Metabolism and Its Roles in Cellular Processes During Ageing. Cell Metabolism.
3. Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD+-Boosting Molecules. Cell Metabolism.
4. Verdin E. NAD+ in Ageing, Metabolism and Neurodegeneration. Science.
5. National Institutes of Health (NIH). Nicotinamide Adenine Dinucleotide (NAD+) and Cellular Metabolism.
6. National Institute on Aging. NAD+ and Healthy Ageing Research.
7. UpToDate. Overview of Intravenous Therapy and Patient Safety.
8. National Institute for Health and Care Excellence (NICE). Intravenous Fluid Therapy in Adults.